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Abstract The human TRIP-1 (transforming growth factor-L
(TGBL)-receptor interacting protein-1) cDNA encodes a protein
able to associate specifically with the type II TGFL receptor. It is
phosphorylated on serine and threonine by this receptor kinase
which makes it a strong candidate as part of the TGFL signal
transduction pathway. We have isolated the genomic sequence of
TRIP-1 and found that the complete coding region is organised
into 11 exons ranging from 39 to 397 bp and spanning
approximately 9 kb of genomic DNA. The 5P flanking region
lacks a TATA box but is GC-rich, suggesting that it is a
constitutively expressed gene which is in agreement with its wide
pattern of expression. Fluorescence in situ hybridisation mapped
the TRIP-1 gene to chromosome 1p34.1 whereas a pseudogene is
located on chromosome 7q32.
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1. Introduction
The transforming growth factor L (TGFL) family of growth
factors controls a wide range of biological processes a¡ecting
cell growth, di¡erentiation and development. Signalling is
mediated by two types of serine/threonine kinase membrane
receptors. Upon binding of the ligand to the transmembrane
receptor complex, probably a heterotetramer, type II receptor
kinase phosphorylates the type I receptor through which the
signal is then propagated intracellularly [1,2].
Some components of the TGFL signalling pathway have
been recently identi¢ed. They form a new protein family,
named Mad proteins. Members of this family have been iso-
lated from Drosophila, Caenorhabditis elegans, Xenopus,
mouse and human [1,2]. The present model of TGFL signal
transduction proposes that ligand-dependent activation of re-
ceptor kinase initiates a cascade of phosphorylation events
allowing the translocation of new phosphorylated Mad pro-
teins into the nucleus where they associate with speci¢c DNA
binding proteins to bind to the promoter of responsive genes
and activate transcription [3,4].
Additional potential candidates for this signal transduction
pathway have been identi¢ed using the yeast two-hybrid sys-
tem [5^7]. One of them, named TGFL-receptor interacting
protein-1 (TRIP-1), has been shown to speci¢cally associate
only with type II TGFL receptor having no a⁄nity to type I
or activin receptors [5]. TRIP-1 is phosphorylated by the het-
eromeric TGFL receptor complex but not by the activin re-
ceptors, which strongly suggests that it is implicated in TGFL
signal transduction. The 1.3 kb long mRNA is expressed ubiq-
uitously and appears to be regulated in parallel to type II
TGFL receptor during development. The 325 amino acid
long TRIP-1 protein contains ¢ve WD domains [8] and a
putative ATP/GTP binding site. The family of WD proteins
is characterised by at least four highly conserved repeating
units usually ending with Trp-Asp (WD). It has been pro-
posed that WD repeats might be involved in protein-protein
interactions. Recently, biochemical puri¢cation and subse-
quent cloning of p36, a subunit of translation initiation factor
eIF3, has been reported and it was found that human p36 is
identical with TRIP-1 [9]. How and whether TRIP-1 is in-
volved in such di¡erent processes as signal transduction and
translation initiation remains to be determined. The genomic
organisation of TRIP-1 was determined, including the exon
and intron sizes, the exon-intron boundaries, and the pro-
moter £anking region. The TRIP-1 gene was mapped by £uo-
rescence in situ hybridisation (FISH) to the chromosomal
region 1p34.1. A TRIP-1-related pseudogene was also identi-
¢ed and mapped to 7q32.
2. Materials and methods
Conditions for human genomic library screening and for PCR con-
ditions have been described previously [14]. Brie£y, RT product was
ampli¢ed in a 100 Wl reaction containing 50 pmol of each oligonucleo-
tide primer, 200 mM of each dNTP, 1.5 mM MgCl2, 10 mM Tris (pH
8.3), 50 mM KCl, and 2 U Taq polymerase. Ampli¢cation conditions
were 94‡C for 2 min followed by 45 cycles of 64‡C for 1 min, 72‡C for
1 min, and 94‡C for 1 min. Ampli¢ed fragments were subcloned in
pBluescript vector (Stratagene). The identity of the ampli¢ed clones
was con¢rmed by nucleotide sequencing.
FISH was performed as previously described [14] using as hybrid-
isation probe the TRIP-1 cDNA and in a separate experiment, DNA
from Sp2 and Sp3 phages.
3. Results and discussion
A human genomic library from placenta was screened with
a cDNA probe corresponding to the complete TRIP-1 coding
sequence. This procedure resulted in the isolation of ¢ve
independent phages. Restriction and Southern blot analysis
showed that two phages (Sp3 and Sp2) contained most of
the TRIP-1 genomic sequences although these phages did
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not overlap (Fig. 1). Suitable DNA restriction fragments
were subcloned into the pBluescript vector for further
analysis. Coding regions were initially identi¢ed by sequence
analysis with oligonucleotides designed on the cDNA-derived
coding sequence. Exon/intron boundaries were sequenced
in both directions. Sequencing analysis indicated that
phage Sp3 contained exons I and II and extended in the 5P
£anking region, while phage Sp2 contained exons V^XI (Fig.
1).
The region carrying exons III and IV, which was not rep-
resented in the genomic clones isolated, was obtained by PCR
of human genomic DNA. A ¢rst clone, named p48/45, was
ampli¢ed using primers designed on the cDNA sequence cor-
responding to exon II, oligo cs48 (5P-GCCATGAGCGGTC-
CATTACGCAGATTA-3P), and to exon III, oligo cs45 (5P-
ACAGCTCCGGTATGGCCCATGTAGGT-3P). The second
clone, named p38/41, was ampli¢ed with a second set of oli-
gonucleotides derived from the cDNA sequence correspond-
ing to exon III, cs38 (5P-ATCGTCAATGTATGGTACTC-
TGTGAATGGT-3P) and from the genomic sequence corre-
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Fig. 1. Map of the TRIP-1 gene with its location of exons and introns and restriction sites. The locations of BamHI (B), EcoRI (E), PstI (P),
XbaI (X), SacI (S) are indicated above the line. Exons are shown as black boxes separated by a line representing introns or £anking regions.
The thick line refers to genomic regions that were sequenced. Sp2 and Sp3 indicate the genomic regions covered by the two lambda phages.
p48/45 and p38/41 are the two genomic fragments ampli¢ed by polymerase chain reaction. The subclones derived from the lambda Sp2 and
Sp3 are indicated by their sizes in kilobases followed by the initial restriction enzymes used for subcloning and the number 2 or 3 depending
on whether they were cloned from the two lambda phage Sp2 or Sp3.
Table 1
Exon-intron boundaries of TRIP-1
3P acceptor sequence Exon Position of exon Exon size (bp) 5P donor sequence Intron Intron size (bp) Reading frame
Intron Exon Exon Intron
I 337^3 40 GGGATG gtgagtttca 1 93 0
met
gtccccacag AAGCCG II 4^96 93 GACCCT gtgagtgttg 2 V1400 0
lyspro asppro
acaaaaccag ATCGTC III 97^184 88 CTGACT gtatccttatt 3 288 I
lylysg laaspt
aactcttcag GGGACA IV 185^250 66 AAACAG gtaagctggg 4 V1000 0
rpaspt aspcys
ctgactccag GAAAGC V 251^400 150 AGATTG gtgagggctg 5 82 I
gluthr lnilea
ccccacacag ACAACA VI 401^528 128 GCCAAG gtaagaggcc 6 V1600 0
spasna alalys
ccttccctag TCTGGA VII 529^639 111 GCCAAG gtgagcctgg 7 119 0
sergly alalys
ctctctccag CTTTTT VIII 640^729 90 GACCAT gtaagagaac 8 V1000 0
leuphe asphis
ttccattcag GTGGTC IX 730^803 74 GGCCAG gtaaagaaga 9 V1950 II
valval ualaar
tttcctccag GTTCTT X 804^896 93 CAAGAG gtagggtacc 10 95 II
gpheph ylysse
ctttttccag CTACAG XI 897^1293 397
rtyrse
Exon sequence is in uppercase letters and intron sequence is in lowercase letters. The position of the exons is given according to the numbering of
the previously published cDNA sequence [5]. The reading frame is indicated by 0 if the intron is positioned between codons. Interruption of the
codon after the ¢rst nucleotide is frame I, and interruption after the second nucleotide is frame II.
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sponding to intron 4, cs41 (5P-ACTTCTTACCTAGACTC-
TTTCCTCGAC-3P).
Fig. 1 shows the restriction map of the TRIP-1 gene with
the subcloned fragments indicated. The TRIP-1 gene is dis-
tributed over 9 kb and divided into 11 exons ranging from 39
to 397 bp in size (Table 1). The coding region sequence of the
exons is identical with the TRIP-1 cDNA sequence reported
by Chen et al. [5].
The ¢rst 8 bp in the 5P untranslated region of the TRIP-1
cDNA reported by Chen et al. [5] are not found in our ge-
nomic sequence or in the sequence of ¢ve cDNAs found by
screening an expression sequence tag (EST) database with the
5P region of the TRIP-1 cDNA. These clones have homology
to our genomic sequence upstream of the ATG in exon I.
Comparing the sequence of EST clone 56792, which extends
more 5P than others, against our genomic sequence we
detected a match for positions 1^7 of the EST clone with
nucleotides at positions 1065^1071 of the genomic sequence.
On the basis of this homology we tentatively extend the
5P untranslated region to 36 nucleotides upstream of the
ATG codon. A visual inspection of the genomic sequence
(1064 bp) upstream of the 5P untranslated region does not
evidence a consensus sequence with signi¢cant similarity to
the initiator sequence already described [10,11]. The termina-
tion codon in exon 11 is followed by 301 nt of non-coding
sequence.
Compared to the published TRIP-1 cDNA sequence we
detected some nucleotide divergences in the 3P non-coding
region which are an insertion of T at position 1067, an inser-
tion of a C at position 1134, deletion of the 8 nucleotides
AAAAATAC starting from position 1146, and two substitu-
tions from T to G at position 1249 and from A to G at
position 1329.
A total of more than 1 kb sequence 5P to the start of the
published cDNA was obtained. Neither a good consensus
sequence for a TATA box nor a CCAAT box was evident.
Typical features of a TATA-less promoter are a high GC
content [12] and the presence of Sp1 binding sites. Indeed,
this region has an overall high GC content of 55%, which
increases to 61% for the 200 bp immediately upstream of
the translation start site which contains several Sp1 binding
sites as observed in several TATA-less promoters. These char-
acteristics would agree with TRIP-1 being a housekeeping
gene which is in line with the ¢nding that TRIP-1 RNA is
ubiquitously expressed [5].
The intron/exon organisation of the TRIP-1 gene is re-
ported in Table 1: the sizes of the introns are between 82
bp and 1950 bp and all exon/intron junction sequences con-
form to the GT/AG rule [13]. According to Southern blot and
sequence analysis (data not shown) there are some repetitive
elements within the 5P untranslated region, in introns 4 and 9
and in the 3P untranslated region.
The other three isolated phages (Sp1, Sp4, Sp5) share a
common restriction pattern. Therefore, only phage Sp1, carry-
ing the largest insert, was analysed further. Sequence analysis
of subcloned fragments revealed that the EcoRI 4 kb fragment
of the SP1 phage carries a sequence with 77% identity to the
part of the TRIP-1 cDNA corresponding to exons III^XI.
This sequence lacks introns suggesting that it represents a
TRIP-1 pseudogene likely originated by a retroposition event
(A. Alloni, data not shown). Southern blot analysis of human
genomic DNA, hybridised with both TRIP-1 genomic and
cDNA probes (not shown), indicates that there is only one
TRIP-1 gene and one related pseudogene.
Chromosomal assignment of the human TRIP-1 gene was
performed by FISH [14] using as hybridisation probe the
TRIP-1 cDNA and, in a separate experiment, DNA from
Sp2 and Sp3 phages. The map position was determined by
visual inspection of the £uorescent hybridisation signals on
DAPI-stained metaphase chromosomes. Only those chromo-
somes with signals present on both chromatids at the same
band position were taken into consideration. The probe was
considered mapped when the same chromosome band showed
signals in not less than 20% of 200 metaphases examined. For
both probes, analysis of metaphase chromosomes conclusively
indicated that the TRIP-1 gene is localised to human chromo-
some 1p34.1. Hybridisation with total DNA from phage Sp1
unequivocally mapped the TRIP-1 pseudogene to chromoso-
mal region 7q32 (Fig. 2).
The 1p34.1 region has been found to be altered in some
human neoplasias [15]. Given the evidence that TGFL inhibits
cell growth and that alterations in genes that encode proteins
involved in TGFL-speci¢c signalling have been identi¢ed
[16,3,17], whether structural alterations are involved with the
TRIP-1 gene in human tumours is under investigation. Pre-
liminary results revealed no gross rearrangement in the TRIP-
1 gene on Southern blot analysis of human primary tumours
(N. Fracchiolla, A. Neri et al., unpublished observations).
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